ADJUVANTE TUMORCHEMOTHERAPIE IM GESAMTKONZEPT DER KLINISCHEN ONKOLOGIE = LA CHIMIOTHERAPIE ADJUVANTE DANS LA CONCEPTION GLOBALE DE L'ONCOLOGIE CLINIQUETANNEBERGER S.1980; ARCH. GESCHW.-FORSCH.; DDR; DA. 1980; VOL. 50; NO 2; PP. 160-164; ABS. ENG; BIBL. 14 REF.Article

REALE FORTSCHRITTE, UNGELOESTE PROBLEME UND PERSPEKTIVEN DER ANTINEOPLASTICHEN CHEMOTHERAPIE BEIM MAMMAKARZINOM = PROGRES REELS, PROBLEMES INSOLUBLES ET PERSPECTIVES DE LA CHIMIOTHERAPIE DU CANCER DU SEINTANNEBERGER S.1982; SITZUNGSBERICHTE DER AKADEMIE DER WISSENSCHAFTEN DER DDR. MATHEMATIK, NATURWISSENSCHAFTEN, TECHNIK; ISSN 0138-3965; DDR; DA. 1982; NO 5; 20 P.; BIBL. 2 P.Serial Issue

THERAPEUTISCHE UND PROGNOSTISCHE KONSEQUENZEN DER PATHOLOGISCH-ANATOMISCHEN DIAGNOSE EINES MALIGNEN NICHT-HODGKIN-LYMPHOMES = CONSEQUENCES THERAPEUTIQUES ET PRONOSTIQUES DU DIAGNOSTIC ANATOMOPATHOLOGIQUE D'UN LYMPHOME NON HODGKINIENTANNEBERGER S.1979; ARCH. GESCHW.-FORSCH.; DDR; DA. 1979; VOL. 49; NO 8; PP. 740-746; ABS. ENG; BIBL. 14 REF.Article

CHEMOTHERAPEUTISCHE STUDIEN UNTER BERUECKSICHTIGUNG DES ONKOBIOGRAMMS = ETUDES CHIMIOTHERAPEUTIQUES EN CONSIDERANT L'ONCOBIOGRAMMEMATTHIAS M; MATTHES T; TANNEBERGER S et al.1975; Z. ERKRANK. ATMUNGSORGANE; DTSCH.; DA. 1975; VOL. 142; NO 2; PP. 132-139; ABS. ANGL.; BIBL. 20REF.Article

BIOLOGICAL CHARACTERIZATION OF A MESOTHELIOMA LINE IN NUDE MICE. I: TRANSPLANTATION OF IN VITRO CULTIVATED CELLS OF A HUMAN ASCITIC TUMOR EFFUSIONARNOLD W; NAUNDORF H; WILDNER GP et al.1979; ARCH. GESCHW.-FORSCH.; DDR; DA. 1979; VOL. 49; NO 6; PP. 495-507; ABS. GER; BIBL. 20 REF.Article

THERAPEUTISCHE EFFEKTIVITAET VON CARMINOMYCIN (CRM) IN DER KOMBINATION MIT DIBROMODULCITOL (DBD) IM VERGLEICH ZUR KOMBINATION VINCRISTIN, CYCLOPHOSPHAMID METHOTREXAT, 5-FLUOROURACIL (VCMF) AN VERSCHIEDENEN TUMORMODELLEN = EFFICACITE THERAPEUTIQUE DE LA CARMINOMYCINE (CRM) EN ASSOCIATION AVEC LE DIBROMODULCITOL (DBD), PAR COMPARAISON AVEC UNE ASSOCIATION VINCRISTINE, CYCLOPHOSPHAMIDE+METHOTREXATE+FLUOROURACILE (VCMF) DANS QUELQUES SYSTEMES TUMORAUXNOWAK C; ARNOLD W; HENNEBERGER G et al.1980; ARCH. GESCHWULSTFORSCH.; ISSN 0003-911X; DDR; DA. 1980; VOL. 50; NO 8; PP. 747-757; ABS. ENG; BIBL. 43 REF.Article

LA RADIO- ET LA CHIMIO-THERAPIE COMPLEMENTAIRES DU TRAITEMENT CHIRURGICAL DU CANCER BRONCHO-PULMONAIREWIDOW W; MATTHESS T; TANNEBERGER S et al.1974; BRONCHES; FR.; DA. 1974; VOL. 24; NO 3; PP. 126-136; BIBL. 18REF.Article

RECENT RESULTS WITH CLINICALLY USED ANTINEOPLASTIC DRUGS AND DRUG COMBINATIONS IN VIVOARNOLD W; TANNEBERGER S; NOWAK C et al.1980; ONCOLOGY; ISSN 0030-2414; CHE; DA. 1980; VOL. 37; SUPPL. 1; PP. 34-41; BIBL. 12 REF.Article

BIOLOGICAL CHARACTERIZATION OF A MESOTHELIOMA LINE IN THE NUDE MICE. II: SOME CHARACTERISTICS OF CELLS CULTIVATED IN VITRO PRIOR TO AND OTHER TRANSPLANTATION IN NUDE MICENISSEN E; ARNOLD W; WEISS H et al.1979; ARCH. GESCHW.-FORSCH.; DDR; DA. 1979; VOL. 49; NO 6; PP. 544-550; ABS. GER; BIBL. 12 REF.Article

Is ondansetron too expensive ?PANNUTI, F; TANNEBERGER, S; LELLI, G et al.Lancet (British edition). 1992, Vol 339, Num 8793, pp 614-615, issn 0140-6736Article

Technical progress, the concept of individualized cancer treatment and the innovation of computer-assisted radiotherapy planningMERKLE, K; TANNEBERGER, S; MATSCHKE, S et al.Radiobiologia, radiotherapia. 1985, Vol 26, Num 6, pp 703-710, issn 0033-8184Article

EXPERIMENTELLE BEFUNDE MIT EINEM NEUEN TYP VON FUNGIZIDEN = RESULTATS EXPERIMENTAUX AVEC UN NOUVEAU TYPE DE FONGICIDESWOHLRAB W; WOZNIAK KD; SCHWABE K et al.1982; MYKOSEN; ISSN 0027-5557; DEU; DA. 1982; VOL. 25; NO 9; PP. 487-496; 8 P.; ABS. ENG; BIBL. 18 REF.Article

Determination of antineoplastic activity and toxicity of tumor necrosis factor (TNF) in animal experiments. correlation to clinical findingsFICHTNER, I; LEMM, M; BECKER, M et al.Neoplasma. 1990, Vol 37, Num 3, pp 301-315, issn 0028-2685Article

Phase II clinical trial of high-dose recombinant human tumor necrosis factorLENK, H; TANNEBERGER, S; MÜLLER, U et al.Cancer chemotherapy and pharmacology. 1989, Vol 24, Num 6, pp 391-392, issn 0344-5704Article

Home artificial nutrition in advanced cancerPIRONI, L; RUGGERI, E; TANNEBERGER, S et al.Journal of the Royal Society of Medicine. 1997, Vol 90, Num 11, pp 597-603, issn 0141-0768Article

Synthese von N-(Phosphonoacetyl)-L-asparaginsäure (PALA) = Synthse de l'acide N-(phosphonoacétyl)-L-aspartique (PALA) = Synthesis of N-(phosphonoacetyl)-L-aspartic acid (PALA)GLOEDE, J; GROSS, H; HENKLEIN, P et al.Pharmazie. 1988, Vol 43, Num 6, issn 0031-7144, 434Article

A randomized clinical trial comparing systemic radiotherapy versus chemotherapy versus local radiotherapy in small cell lung cancerHÜTTNER, J; WIENER, N; QUADT, C et al.European journal of cancer & clinical oncology. 1989, Vol 25, Num 6, pp 933-937, issn 0277-5379Article

Aminoglutethimide in advanced breast cancer : prospective, randomized comparison of two dose levelsROBUSTELLI DELLA CUNA, G; PANNUTI, F; MARTONI, A et al.Anticancer research. 1993, Vol 13, Num 6B, pp 2367-2371, issn 0250-7005Conference Paper